Andreas M Hötker1, André Lollert2, Yousef Mazaheri3, Sabine Müller4,5, Jens-Peter Schenk6, Philipp C Mildenberger7, Oguz Akin8, Norbert Graf4, Gundula Staatz2. 1. Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. Andreas.Hoetker@usz.ch. 2. Section of Pediatric Radiology, Department of Diagnostic and Interventional Radiology, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Germany. 3. Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. 4. Department of Pediatric Oncology and Hematology, Saarland University, Kirrberger Straße, 66421, Homburg, Germany. 5. Mathematical Image Analysis Group, Saarland University, Campus E1.7, 66041, Saarbrücken, Germany. 6. Division of Pediatric Radiology, University Hospital Heidelberg, Im Neuenheimer Feld 153, 69120, Heidelberg, Germany. 7. Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Germany. 8. Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Abstract
PURPOSE: To assess the value of diffusion-weighted MRI in the pre-therapeutic evaluation of pediatric renal cortical tumors. METHODS: This IRB-approved, retrospective multi-center study included 122 pediatric patients with 130 renal tumors, who underwent MRI including DWI before neoadjuvant chemotherapy and nephrectomy. Two radiologists independently assessed each tumor volumetrically, and apparent diffusion coefficient (ADC) values were calculated on a voxel-wise basis, including parameters derived from histogram and texture analysis. RESULTS: Inter-reader agreement was excellent (ICC 0.717-0.975). For both readers, patients with locally aggressive tumor growth (SIOP 3 stage) or with metastases (M1) had significantly lower 12.5th-percentile ADC values (p ≤ 0.028) compared to those with lower-stage tumors, and the parameter energy differed significantly between patients with M1 and those with M0 status (p ≤ 0.028). Contrast and homogeneity differed significantly between benign nephroblastomatosis and malignant nephroblastoma (p ≤ 0.045, both readers). As compared to all other subtypes, the blastemal subtype demonstrated significantly higher skewness (p ≤ 0.022, both readers) and the diffuse anaplastic subtype demonstrated significantly higher 75th-percentile ADC values (p ≤ 0.042, both readers). CONCLUSIONS: Diffusion-weighted MRI may be of value in identifying benign nephroblastomatosis and assessing nephroblastoma subtypes. Therefore, further research is warranted to assess its value in risk stratification for pediatric patients with renal tumors in the future.
PURPOSE: To assess the value of diffusion-weighted MRI in the pre-therapeutic evaluation of pediatric renal cortical tumors. METHODS: This IRB-approved, retrospective multi-center study included 122 pediatric patients with 130 renal tumors, who underwent MRI including DWI before neoadjuvant chemotherapy and nephrectomy. Two radiologists independently assessed each tumor volumetrically, and apparent diffusion coefficient (ADC) values were calculated on a voxel-wise basis, including parameters derived from histogram and texture analysis. RESULTS: Inter-reader agreement was excellent (ICC 0.717-0.975). For both readers, patients with locally aggressive tumor growth (SIOP 3 stage) or with metastases (M1) had significantly lower 12.5th-percentile ADC values (p ≤ 0.028) compared to those with lower-stage tumors, and the parameter energy differed significantly between patients with M1 and those with M0 status (p ≤ 0.028). Contrast and homogeneity differed significantly between benign nephroblastomatosis and malignant nephroblastoma (p ≤ 0.045, both readers). As compared to all other subtypes, the blastemal subtype demonstrated significantly higher skewness (p ≤ 0.022, both readers) and the diffuse anaplastic subtype demonstrated significantly higher 75th-percentile ADC values (p ≤ 0.042, both readers). CONCLUSIONS: Diffusion-weighted MRI may be of value in identifying benign nephroblastomatosis and assessing nephroblastoma subtypes. Therefore, further research is warranted to assess its value in risk stratification for pediatric patients with renal tumors in the future.
Entities:
Keywords:
Diffusion-weighted imaging; Magnetic resonance imaging; Nephroblastoma
Authors: Justine N van der Beek; Tom A Watson; Rutger A J Nievelstein; Hervé J Brisse; Carlo Morosi; Henrique M Lederman; Ana Coma; Maria M Gavra; Kristina Vult von Steyern; Karoly Lakatos; Luc Breysem; Edit Varga; Hubert Ducou Le Pointe; Maarten H Lequin; Jürgen F Schäfer; Hans-Joachim Mentzel; Andreas M Hötker; Giuseppina Calareso; Sophie Swinson; Martin Kyncl; Claudio Granata; Michael Aertsen; Pier Luigi Di Paolo; Ronald R de Krijger; Norbert Graf; Øystein E Olsen; Jens-Peter Schenk; Marry M van den Heuvel-Eibrink; Annemieke S Littooij Journal: J Magn Reson Imaging Date: 2021-08-06 Impact factor: 5.119
Authors: Anita Adriaantje Harteveld; Annemieke Simone Littooij; Max Maria van Noesel; Marijn van Stralen; Clemens Bos Journal: MAGMA Date: 2021-08-03 Impact factor: 2.310